February 22, 2024 in Company News

Avance Clinical and Ryght Partner to Bring Novel GenAI Technologies to Clinical Research Networks

February 20, 2024 Avance Clinical and Ryght Partner to Bring Novel GenAI Technologies to Clinical Research Networks Revolutionizing Clinical Research: Accelerate Innovation with GenAI by Ryght & Avance Clinical Laguna…
Read More
January 8, 2024 in Company News

Frost & Sullivan Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner

Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner - Affecting Drug Development Schedules & Financial Plans Avance Clinical, the leading Australian and North American CRO…
Read More
November 17, 2023 in Company News

Avance Clinical Strengthens Asia-Pacific Network with Digital Technology Company JNPMEDI INC

Adelaide, Australia | North Carolina, USA – Avance Clinical, the Australian and North American market-leading CRO for biotechs, has signed a strategic technology MOU with leading Korean decentralized clinical trials…
Read More
October 31, 2023 in Other news

LIVE WEBINAR: PSYCHEDELICS IN FOCUS

Monday, November 27, 2023 | 10am PST / 12pm CST / 1pm EST  Join us for an informative webinar as we delve into the world of psychedelic trials and the…
Read More
October 23, 2023 in Other news

Avance Clinical Finalist In The 61st Australian Export Awards 2023

Adelaide, Australia | North Carolina, USA – Avance Clinical, the award-winning Australian and North American market leading CRO for biotechs, has again been recognized for its contribution to International Health…
Read More
October 19, 2023 in Company News

Avance Clinical Invited To Brief 45 Korean Biotechs On Their Globalready Drug Development Pathway From Korea And Australia To The Us

Dt & SanoMedics Chairman, Charles Park (Park, Chae Gyoo) and Avance Clinical CEO Yvonne Lungershausen co-hosting the Global Clinical Trial Strategy Symposium in Korea last week. Adelaide, Australia | North Carolina,…
Read More
September 27, 2023 in Company News, Other news

Biotech CRO Leader, Avance Clinical, Backs California Life Sciences Entrepreneurship Program With Gold Sponsorship

Adelaide, Australia | North Carolina, USA – Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, is proud to announce its gold sponsorship of California Life Sciences…
Read More
September 21, 2023 in Company News, New Team Members

Avance Clinical Appoints US-Based Executives – SVP Scientific And Regulatory Affairs, And Director Business Development

Adelaide, Australia | Raleigh, North Carolina, USA – Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, announces two key appointments in the US to support its…
Read More
September 18, 2023 in Company Awards, Company News

CEO Of Avance Clinical Nominated For Executive Of The Year In 2023 Citeline Pharma Intelligence Awards Japan

  Adelaide, Australia | North Carolina, USA – Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, is proud to announce that Chief Executive Officer Yvonne Lungershausen…
Read More
September 14, 2023 in Company News, Conference News

Join Avance Clinical In Seoul At KoNECT Korea 2023

Adelaide, Australia | North Carolina, USA – Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will visit Seoul in October to expand on collaborative opportunities with…
Read More
August 7, 2023 in Company Awards, Company News

Avance Clinical Customer Leadership Award Frost & Sullivan Analyst Report

Avance Clinical -Award Writeup Download
Read More
August 7, 2023 in Company Awards, Company News

Avance Clinical Earns Frost & Sullivan’s 2023 Best Practices Customer Value Leadership Award for Delivering High-quality Clinical Trials Based on Globally Accepted Data

Avance Clinical is an Australian and North American market-leading Contract Research Organization (CRO) that provides international biotechs with customized solutions. For the fourth consecutive year, Avance Clinical has been awarded…
Read More
August 1, 2023 in Company News, In the News, Other news

Endpoints News Feature: GlobalReady Saving Trial Cost and Time

Read full article here
Read More
June 29, 2023 in Company News

Avance Clinical Opens New North American Headquarters

  Adelaide, Australia | North Carolina, USA - Avance Clinical the leading award-winning Australian and North American biotech CRO that offers the GlobalReady program to speed up the path to…
Read More
May 30, 2023 in Company News, Conference News

Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients

Adelaide, Australia | San Diego, USA - Avance Clinical the leading award-winning Australian and North American CRO that offers ClinicReady and GlobalReady for early-phase biotech companies to speed up the…
Read More
May 25, 2023 in Company Awards, Company News

Avance Clinical Joins Global Health Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies

Adelaide, Australia | San Diego, USA - Avance Clinical the leading award-winning Australian and North American CRO that offers the programs ClinicReady and GlobalReady for early-phase biotech companies to speed…
Read More
April 18, 2023 in Company News, Conference News

Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023

Adelaide, Australia | San Diego, USA - Avance Clinical the leading award-winning Australian and North American biotech CRO that offers a GlobalReady program to early-phase biotech companies to speed up…
Read More
April 10, 2023 in Company News, In the News

Avance Clinical Leads DCT Technology Adoption Globally

  Adelaide, Australia, North Carolina, USA – GlobalData and Clinical Trial Arena have identified Avance Clinical as the global leader in Decentralized Clinical Trial (DCT) technology adoption with 46% of…
Read More
March 27, 2023 in Client News, Company News

Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373

EB-373, a proprietary psilocin prodrug, is on track to start its first-in-human clinical trial in the fourth quarter of 2023 CAMBRIDGE, Mass. –Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the…
Read More
March 1, 2023 in Company News, New Team Members

Avance Clinical Appoints North America SVP with Global Contract Research Organization, Data Quality and DCT Expertise

Adelaide, Australia | San Diego, USA - Avance Clinical the leading award-winning Australian and North American biotech CRO that offers the GlobalReady program for biotech companies to speed up the…
Read More
February 13, 2023 in Company News, We are hiring

Avance Clinical Expands Biometrics Team into India to Support Biotech Trials Demand in US and Australia

Award-winning CRO Avance Clinical, which currently has the largest Biometrics team in Australia, is expanding further with global hires and a specialist hub in Bangalore, India to support growing demand.…
Read More
January 11, 2023 in Company News

Avance Clinical Celebrates GlobalReady Success as More Than 40 Biotechs Enter Program

More than 40 biotech clients are now taking advantage of Avance Clinical’s GlobalReady program which delivers streamlined clinical development from early phase in Australia expanding to sites in North America…
Read More
December 12, 2022 in Other news

New Analyst Report – Avance Clinical GlobalReady for Biotechs

Avance-Clinical-2022-Global Ready Download
Read More
December 7, 2022 in Other news

Avance Clinical Wins Frost & Sullivan Customer Value Leadership Award 2022

Adelaide, Australia/San Diego, USA – After an extensive review by CRO industry analysts comprising executive interviews and background sector research, Frost & Sullivan has recognized Avance Clinical, the leading Australian-based…
Read More
October 27, 2022 in Other news

Avance Clinical Sponsors China BioPharma Award at the Global Scrip Awards, London

Adelaide, Australia/San Diego, USA – Avance Clinical, the leading Australian-based biotech CRO with US operations will sponsor and present the China BioPharma Award at the global biotech Scrip Awards in…
Read More
September 28, 2022 in Company Awards

Avance Clinical Wins International Health Award for Biotech CRO Services

Australia – Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South Australian Premier’s Export Awards - International Health category. The award recognizes excellence in clinical…
Read More
September 6, 2022 in Company News

AVANCE CLINICAL ANNOUNCES NORTH AMERICAN CRO ACQUISITION TO EXPAND LATER PHASE SERVICES FOR BIOTECHS

      https://vimeo.com/746663903 Sydney, Australia/San Diego, USA – Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research…
Read More
August 24, 2022 in In the News

Avance Clinical MedTech Featured in Endpoints News – Most read article for the month

Innovative MedTech Demands Specialist Clinical Trial Regulatory Affairs and Design As technology becomes increasingly ubiquitous in our lives, the demand for remote or home-based MedTech for real-time condition detection, monitoring…
Read More
August 24, 2022 in Company Video, Partner News

Avance Clinical Featured in Oracle Argus Capabilities Spotlight

Avance Clinical presented real world experience supporting biotech clinical trials using Oracle Argus. Hear from Avance Clinical's Chief Scientific Officer Gabriel Kremmidiotis, and Drug Safety Manager Pilar Garzon in the…
Read More
June 9, 2022 in Company News, Conference News

Avance Clinical Announces at BIO 2022: Expansion Across Australia and New Zealand – New Offices and Double Growth

Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney and Melbourne, with further expansions planned, and increased clinical staff numbers…
Read More
April 19, 2022 in Company Awards, Company News

Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 – Best Contract Research Organization in APAC

Adelaide, Australia – Avance Clinical, the largest premium Australian Contract Research Organization (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC…
Read More
March 31, 2022 in Company News

Avance Clinical Announces New Office Opening in Melbourne

Melbourne, Australia – Avance Clinical, the largest premium Australian Contract Research Organization (CRO) for international biotechs, has opened new offices in Melbourne to support its growing clinical team in the…
Read More
March 3, 2022 in Company News

Avance Clinical Announces Appointment of Liahna Toy as Head of Business Development

Avance Clinical, the largest full-service Australian Contract Research Organization (CRO) for international biotechs, announced today the appointment of Liahna Toy to the new senior executive role, Head of Business Development.…
Read More
March 2, 2022 in Client News, Company News

Brett Favre talks concussion

Listen to football legend Brett Favre on 5AA ‘Rowey’s Sports Show’ talk about concussion in sport and the therapy that leading biotech firm Odyssey Health as in clinical trials with…
Read More
February 14, 2022 in Company News, We are hiring

Avance Clinical Announces New Office Opening in Sydney

Sydney, Australia – Avance Clinical, the largest premium Australian Contract Research Organization (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical team in the…
Read More
November 25, 2021 in Company News

Avance Clinical Featured in Endpoints News on Cell & Gene Therapy Capabilities

The cell and gene therapies (CGT) sector offers unprecedented opportunities for patient disease management across virtually all therapeutic areas. However, finding the right accredited clinical teams to take a therapy…
Read More
October 23, 2021 in Company News

Avance Clinical Featured in Fierce Biotech on Intranasal Expertise

With the global intranasal drug delivery market estimated to reach up to $71 billion over the next five years, Avance Clinical is seeing an increase in biotech clinical trials targeting…
Read More
October 18, 2021 in Client News

Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain

Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma Ltd. has announced dosing of subjects in its first-in-human study…
Read More
August 10, 2021 in Company Awards, Company News

Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership

Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second consecutive Asia-Pacific (APAC)…
Read More
July 9, 2021 in Client News, Company News

Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia

The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for…
Read More
July 9, 2021 in Client News

Avance Clinical Client XWPharma Announces Positive Results from Phase 1 Clinical Trials of XW10172, in Development as Once-Nightly Therapy for Sleep Disorders in Patients with Neurodegenerative Diseases

The leading Australian CRO for international biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client XWPharma on receiving positive results from its Phase 1…
Read More
July 2, 2021 in Company Video

Andy Hu on Avance Clinical – why it is the right CRO for Chinese Biotechs

Read More
June 24, 2021 in Company News

Avance Clinical Announces Appointment of Asia Biotech Specialist to Support APAC Growth

The leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical today announced the appointment of APAC expert Andy Hu as Business Development Manager…
Read More
June 20, 2021 in Company News

Avance Clinical’s USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as…
Read More
June 18, 2021 in Conference News

Avance Clinical at ARCS 2021 Conference

The Avance Clinical team attended the ARCS Annual Conference this week for in-person industry meetings.
Read More
June 10, 2021 in Company News

TrialTrove Data Shows Australia is Open for Business says Avance Clinical at BIO Digital 2020

The leading Australian CRO for biotechs, Avance Clinical announced at BIO Digital today that Australia currently has 2,413 trials planned or ongoing. Importantly in Australia, despite the global COVID-19 pandemic,…
Read More
June 6, 2021 in Company News, Conference News

Avance Clinical’s USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as…
Read More
May 29, 2021 in Company News, Conference News

Avance Clinical Releases Industry Survey Results at BIO Korea 2021 – Data Quality the Top Criteria for Selecting a CRO

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a recent industry survey conducted by the company that found data…
Read More
May 21, 2021 in Company Awards, Company News

Avance Clinical Wins Excellence in Business Award 2021

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical has won the Fast Movers SA Excellence in Business Award 2021 sponsored by international accounting and business advisory…
Read More
May 6, 2021 in Company Awards, Company News

Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand…
Read More